Background Herpes simplex virus type 2 (HSV-2) infection is a prevalent sexually
transmitted infection worldwide. This systematic review was conducted to characterize HSV-2 …

Background Waning of vaccine protection against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The …

Protection against Omicron by Previous SARS-CoV-2 Infection Using a national Covid-19
database in Qatar, investigators found that previous SARS-CoV-2 infection provided protection …

Background Waning of vaccine protection against coronavirus disease 2019 (Covid-19)
and the emergence of the omicron (or B.1.1.529) variant of the severe acute respiratory …

SARS-CoV-2 Omicron BA.1 and BA.2 subvariants are genetically divergent. We conducted
a matched, test-negative, case-control study to estimate duration of protection of the second …

With the global expansion of the highly transmissible SARS-CoV-2 Delta (B.1.617.2) variant,
we conducted a matched test-negative case–control study to assess the real-world …

Background The objective of this study was to characterize herpes simplex virus type 1 (HSV-1)
epidemiology in Canada. Methods HSV-1 publications as recent as December 6, 2021 …

The Middle East and north Africa is one of only two world regions where HIV incidence is on
the rise, with most infections occurring among key populations: people who inject drugs, …

Background Understanding protection conferred by natural SARS-CoV-2 infection versus
COVID-19 vaccination is important for informing vaccine mandate decisions. We compared …

COVID-19 vaccine protection against infection in immunosuppressed solid organ transplant
recipients is unknown but possibly weak with the low proportion of these patients mounting …